CRB3 and cancer: To further examine whether CRB3 downregulation conferred cancer stem cell traits through activation of β‐catenin signalling in tamoxifen‐resistant cells, we assessed whether CRB3 up‐regulation could reduce β‐catenin expression and affect subcellular localization of β‐catenin protein.